siRNA and the lung: research tool or therapeutic drug?

Current Opinion in Pharmacology

Volumn 8, Issue 3, 2008, Pages 280-285

  de Fougerolles, Antonin ^a   Novobrantseva, Tatiana ^a  

^a ALNYLAM PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALN RSV 01; ANGIOPOIETIN 2; ANTISENSE OLIGONUCLEOTIDE; CAVEOLIN 1; CELL PENETRATING PEPTIDE; CHITOSAN; FAS ANTIGEN; HEME OXYGENASE 1; LIPOPLEX; LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; POLYETHYLENEIMINE; SMALL INTERFERING RNA;

ACUTE LUNG INJURY; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG TARGETING; DRUG TOLERABILITY; DRUG UPTAKE; GENE EXPRESSION; GENE SILENCING; HUMAN; INFLUENZA; LIPOSOMAL GENE DELIVERY SYSTEM; LUNG FIBROSIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OLIGONUCLEOTIDE THERAPY; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; REVIEW; RNA INTERFERENCE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL RESPIRATORY TRACT INFECTION;

ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; INFLUENZA, HUMAN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT DISEASES; RNA, SMALL INTERFERING; VEHICLES;

EID: 44649091252     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2008.04.005     Document Type: Review

References (31)

1. Aagaard L., and Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 59 (2007) 75-86
2. Bumcrot D., Manoharan M., Koteliansky V., and Sah D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2 (2006) 711-719
3. de Fougerolles A., Vornlocher H.P., Maraganore J., and Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6 (2007) 443-453
4. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., and Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 441 (2006) 537-541
5. John M., Constien R., Akinc A., Goldberg M., Moon Y.A., Spranger M., Hadwiger P., Soutschek J., Vornlocher H.P., Manoharan M., et al. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway. Nature 449 (2007) 745-747
6. Novobrantseva TNA A., Borodovsky A., and de Fougerolles A. Delivering silence: advancements in developing siRNA therapeutics. Curr Opin Drug Discov Devel 11 (2008) 217-224
7. de Fougerolles A. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther 19 (2008) 125-132
8. Bitko V., Musiyenko A., Shulyayeva O., and Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 11 (2005) 50-55. More than three orders of magnitude viral load reduction by intranasally administered saline-formulated siRNA in doses as low as 70 g per animal.
9. Li B.J., Tang Q., Cheng D., Qin C., Xie F.Y., Wei Q., Xu J., Liu Y., Zheng B.J., Woodle M.C., et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 11 (2005) 944-951. Antiviral activity of direct intranasal instillation of saline-formulated siRNA in the lung of nonhuman primates is demonstrated in this study.
10. Ge Q., Filip L., Bai A., Nguyen T., Eisen H.N., and Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A 101 (2004) 8676-8681
11. Thomas M., Lu J.J., Ge Q., Zhang C., Chen J., and Klibanov A.M. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci U S A 102 (2005) 5679-5684
12. Tompkins S.M., Lo C.Y., Tumpey T.M., and Epstein S.L. Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci U S A 101 (2004) 8682-8686
13. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 11 (2005) 263-270
14. Morrissey D.V., Lockridge J.A., Shaw L., Blanchard K., Jensen K., Breen W., Hartsough K., Machemer L., Radka S., Jadhav V., et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 23 (2005) 1002-1007
15. Zhang X., Shan P., Jiang D., Noble P.W., Abraham N.G., Kappas A., and Lee P.J. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 279 (2004) 10677-10684. Report demonstrating endogenous target silencing in the lung through intranasal delivery of saline-formulated HO-1 siRNA.
16. Bhandari V., Choo-Wing R., Lee C.G., Zhu Z., Nedrelow J.H., Chupp G.L., Zhang X., Matthay M.A., Ware L.B., Homer R.J., et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12 (2006) 1286-1293. Chemically modified siRNA targeting Ang2 and delivered intranasally is shown to effectively reduce lung pathology and mouse morbidity.
17. Lomas-Neira J.L., Chung C.S., Wesche D.E., Perl M., and Ayala A. In vivo gene silencing (with siRNA) of pulmonary expression of MIP-2 versus KC results in divergent effects on hemorrhage-induced, neutrophil-mediated septic acute lung injury. J Leukoc Biol 77 (2005) 846-853
18. Perl M., Chung C.S., Lomas-Neira J., Rachel T.M., Biffl W.L., Cioffi W.G., and Ayala A. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am J Pathol 167 (2005) 1545-1559
19. White A.F., and Ponnazhagan S. Airway epithelium directed gene therapy for cystic fibrosis. Med Chem 2 (2006) 499-503
20. Ziady A.G., and Davis P.B. Current prospects for gene therapy of cystic fibrosis. Curr Opin Pharmacol 6 (2006) 515-521
21. Birchall J. Pulmonary delivery of nucleic acids. Expert Opin Drug Deliv 4 (2007) 575-578
22. Weiss D.J. Delivery of DNA to lung airway epithelium. Methods Mol Biol 246 (2004) 53-68
23. Griesenbach U., Kitson C., Escudero Garcia S., Farley R., Singh C., Somerton L., Painter H., Smith R.L., Gill D.R., Hyde S.C., et al. Cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. Respir Res 7 (2006) 26
24. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.O., Hovgaard M.B., Schmitz A., Nyengaard J.R., Besenbacher F., et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 14 (2006) 476-484. The authors introduce chitosan-based siRNA nanoparticles and demonstrate in vivo RNA interference in bronchiole epithelial cells.
25. Zhang W., Yang H., Kong X., Mohapatra S., San Juan-Vergara H., Hellermann G., Behera S., Singam R., Lockey R.F., and Mohapatra S.S. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 11 (2005) 56-62
26. Liu X., Howard K.A., Dong M., Andersen M.O., Rahbek U.L., Johnsen M.G., Hansen O.C., Besenbacher F., and Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 28 (2007) 1280-1288
27. Moschos S.A., Williams A.E., and Lindsay M.A. Cell-penetrating-peptide-mediated siRNA lung delivery. Biochem Soc Trans 35 (2007) 807-810
28. de Jonge J., Holtrop M., Wilschut J., and Huckriede A. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs. Gene Ther 13 (2006) 400-411
29. Miyawaki-Shimizu K., Predescu D., Shimizu J., Broman M., Predescu S., and Malik A.B. siRNA-induced caveolin-1 knockdown in mice increases lung vascular permeability via the junctional pathway. Am J Physiol Lung Cell Mol Physiol 290 (2006) L405-L413
30. Lively T.N., Kossen K., Balhorn A., Koya T., Zinnen S., Takeda K., Lucas J.J., Polisky B., Richards I.M., and Gelfand E.W. Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice. J Allergy Clin Immunol 121 (2008) 88-94
31. Matsuyama W., Watanabe M., Shirahama Y., Hirano R., Mitsuyama H., Higashimoto I., Osame M., and Arimura K. Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation. J Immunol 176 (2006) 1928-1936